Highlights
ASX: RCE       RECCE PHARMACEUTICALS LTD
Last Price Today's Change   Day's Range   Trading Volume
0.26   -0.01 (3.70%)  0.255 - 0.27  499,196

Overview

 
Avg Volume (4 weeks):437,816
4 Weeks Range:0.25 - 0.305
4 Weeks Price Volatility (%):
18.18%
52 Weeks Range:0.13 - 0.435
52 Weeks Price Volatility (%):
42.62%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Recce Limited is an Australia-based research-based pharmaceutical company. The Company is principally engaged in research and development of antibiotic drugs and anticancer drugs. The Company's antibiotics kill both susceptible bacteria and drug resistant super bugs throughout the world health danger arising from resistance to present-day antibiotics. The Company offers antibiotic drugs to treat the diseases caused by Sepsis, Helicobacter Pylori (H.Pylori), Escherichia coli (E.coli), Gonorrhea and Tuberculosis (TB). The Company offers anticancer drugs to treat various cancers, such as leukemia, prostate, lung, stomach, intestine, kidney and melanoma. The Company also offers polymer-antibiotics targeted for human use. The Company's Recce antibiotic kills all types of bacteria, including superbugs. Its subsidiaries include Recce (USA) LLP and Recce (UK) Limited.

  Be the first to like this.
 


 

568  561  815  2415 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 IMU 0.045+0.003 
 NHL 0.075+0.012 
 FFG 0.013+0.003 
 AUZ 0.017+0.002 
 BD1 0.032-0.003 
 TLS 3.60+0.02 
 ECT 0.0010.00 
 MLX 0.18-0.025 
 ADN 0.051+0.006 
 AVH 0.585-0.005 
Partners & Brokers